Source: Immunotherapy. Unidades: ICB, FM
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Lais Teodoro da et al. Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine?. Immunotherapy, v. 5, n. 12, p. 1305-1311, 2013Tradução . . Disponível em: https://doi.org/10.2217/imt.13.136. Acesso em: 27 ago. 2024.APA
Silva, L. T. da, Pontillo, A., Silva, W. C. da, Almeida, A. de, Duarte, A. J. da S., & Oshiro, T. M. (2013). Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine? Immunotherapy, 5( 12), 1305-1311. doi:10.2217/imt.13.136NLM
Silva LT da, Pontillo A, Silva WC da, Almeida A de, Duarte AJ da S, Oshiro TM. Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine? [Internet]. Immunotherapy. 2013 ; 5( 12): 1305-1311.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2217/imt.13.136Vancouver
Silva LT da, Pontillo A, Silva WC da, Almeida A de, Duarte AJ da S, Oshiro TM. Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine? [Internet]. Immunotherapy. 2013 ; 5( 12): 1305-1311.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2217/imt.13.136